Briacell Therapeutics Corp at Benzinga Global Small Cap Investor Conference (Virtual) Transcript
Ladies and gentlemen, coming up next, the chat is super hype about this next presentation and why not. Let's bring him on here. Here we have Bill Williams from BriaCell. Its ticker BCTX.
Bill, how you doing today?
Doing great. It's great to join you at Bezinga here, Brent.
Yes. Like I said, the chat out in the YouTube land is absolutely excited for the presentation today. So I'll let you have at it, Bill. Take it away.
Great. Thanks so much. Of course, we have forward-looking statements in here. Just a brief snapshot of our cap structure. We are a preclinical -- not preclinical, pre-revenue company in biotech. So a little bit different than what you were just looking at for urban-gro. But share price around $9; shares outstanding, 15.5 million or so, market cap about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |